Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin. [electronic resource]
Producer: 20170111Description: 491-7 p. digitalISSN:- 1437-7772
- Adult
- Aged
- Antiemetics -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Aprepitant
- Carboplatin -- administration & dosage
- Dexamethasone -- therapeutic use
- Double-Blind Method
- Drug Hypersensitivity -- etiology
- Drug Therapy, Combination
- Female
- Genital Neoplasms, Female -- drug therapy
- Humans
- Middle Aged
- Morpholines -- therapeutic use
- Nausea -- chemically induced
- Paclitaxel -- administration & dosage
- Remission Induction
- Serotonin 5-HT3 Receptor Antagonists -- therapeutic use
- Vomiting -- chemically induced
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.